May 2020
The Health & Safety Executive (HSE) has issued comprehensive guidance to employers about working with COVID-19:
The HSE and the Police are considering prosecution of employers who have failed to provide proper protection for key workers, including corporate manslaughter prosecutions:
Researchers at Royal Melbourne Hospital in Australia have launched the AustralaSian Covid-19 trial (ASCOT) to assess the safety and effectiveness of lopinavir/ritonavir and hydroxychloroquine in hospitals:
The May 2020 updated COVID-19 pipeline report from VPA Research presents the most recent updates on drug candidates and vaccine candidates that will potentially reach the market in the next 2 years:
Leading Asia Pacific CRO Novotech is producing a series of free Whitepapers on how Australian and Asia-Pacific clinical trial companies are responding to the need for their vital work during the COVID-19 pandemic:
novotech-cro.comGlobalData is offering a free COVID-19 Executive Briefing report to explain the COVID-19 outbreak, its economic impact, and implications for specific sectors:
DIA Europe 2020 will take place on 29 June - 3 July in a Virtual Format:
The 5-day Excellence in Pharmacovigilance Training Course, organised jointly by the Medicines Evaluation Board and DIA, will continue as planned on 15-19 June, but in a Live Virtual format:
The World Health Organization (WHO) has issued multiple technical guidance documents on Laboratory testing for 2019-nCoV in humans: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance
America’s Centers for Disease Control and Prevention (CDC) have produced a comprehensive Q&A on COVID-19 Testing and Reporting by Laboratories: https://www.cdc.gov/coronavirus/2019-ncov/lab/testing-laboratories.html
Cambridge University has established a new laboratory to help meet the UK government’s 100,000-a-day target. The facility at the Anne McLaren Lab is the result of a collaborative effort between Cambridge University, AstraZeneca and GlaxoSmithKline: https://thetab.com/uk/cambridge/2020/04/08/cambridge-university-opens-new-laboratory-in-attempt-to-meet-uks-ambitious-covid-19-testing-goals-135317
AstraZeneca and Oxford University are partnering to scale a coronavirus vaccine that has already entered Phase 1 trials: https://www.biopharma-reporter.com/Article/2020/04/30/AZ-and-Oxford-University-partner-on-COVID-19-vaccine?utm_source=newsletter_daily&utm_medium=email&utm_campaign=30-Apr-2020
Clinical supply chain and logistics company Marken evaluate how COVID-19 is shaking up the clinical trial supply chain: https://www.outsourcing-pharma.com/Article/2020/04/02/COVID-19-disrupts-clinical-trial-supply-chain?utm_source=newsletter_daily&utm_medium=email&utm_campaign=21-Apr-2020
Arena International Events Group is running a Virtual Experience "Outsourcing in Clinical Trials 2020" at 10 a.m. BST on 27th May. Registration and Agenda here: https://arena-international.com/octvirtual/ plus download "Outsourcing in Clinical Trials Handbook 2020" on the same link.
Transperfect Lifesciences’ three Clinical Trials and COVID-19 Webinars, held in April, are now available to watch online. Part 1: Clinical Trials and COVID-19: Situation now, its challenges, and the future; Part 2: Converting to Remote Trial Management – How to Get Started; and Part 3: Adapting to Rapid Change: https://lifesciences.transperfect.com/webinar?utm_term=View%20more%20webinars&utm_campaign=Webinar%20Series%20-%20Part%201%3A%20Clinical%20Trials%20and%20COVID-19&utm_content=landing+page&utm_source=Act-On+Software&utm_medium=landing+page
Covid-19 makes the future of UK clinical research uncertain: https://www.bmj.com/content/369/bmj.m1619?utm_source=twitter&utm_medium=social&utm_term=hootsuite&utm_content=sme&utm_campaign=usage
